Landscape Capital Management L.L.C. Increases Stake in The Chemours Company $CC

Landscape Capital Management L.L.C. raised its holdings in shares of The Chemours Company (NYSE:CC) by 31.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 133,428 shares of the specialty chemicals company’s stock after buying an additional 31,639 shares during the period. Landscape Capital Management L.L.C. owned about 0.09% of Chemours worth $1,573,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund increased its holdings in Chemours by 1.8% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 34,300 shares of the specialty chemicals company’s stock valued at $404,000 after buying an additional 600 shares during the last quarter. PFG Investments LLC increased its holdings in Chemours by 7.6% during the fourth quarter. PFG Investments LLC now owns 12,494 shares of the specialty chemicals company’s stock valued at $147,000 after buying an additional 883 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Chemours by 1.2% during the fourth quarter. State of Alaska Department of Revenue now owns 76,257 shares of the specialty chemicals company’s stock valued at $899,000 after buying an additional 932 shares during the last quarter. Man Group plc increased its holdings in Chemours by 0.4% during the second quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock valued at $3,104,000 after buying an additional 979 shares during the last quarter. Finally, Rothschild Investment LLC increased its holdings in Chemours by 87.0% during the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 1,255 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Truist Financial upped their target price on shares of Chemours from $27.00 to $30.00 and gave the company a “buy” rating in a report on Tuesday, April 28th. Alembic Global Advisors reissued an “overweight” rating and issued a $30.00 price objective on shares of Chemours in a research note on Wednesday, May 13th. Mizuho set a $30.00 price objective on shares of Chemours in a research note on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of Chemours from $26.00 to $29.00 and gave the stock an “outperform” rating in a research note on Monday, May 11th. Finally, Zacks Research raised shares of Chemours from a “strong sell” rating to a “hold” rating in a research note on Friday, April 24th. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Chemours currently has an average rating of “Hold” and a consensus target price of $24.60.

Chemours Stock Performance

Shares of NYSE CC opened at $22.40 on Tuesday. The firm has a fifty day moving average price of $23.07 and a 200-day moving average price of $18.49. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.82 and a quick ratio of 0.87. The stock has a market cap of $3.37 billion, a PE ratio of -8.48 and a beta of 1.40. The Chemours Company has a 1 year low of $10.14 and a 1 year high of $28.67.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.13 earnings per share. Equities analysts anticipate that The Chemours Company will post 1.07 earnings per share for the current fiscal year.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Sunday, May 17th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, May 15th. Chemours’s dividend payout ratio (DPR) is presently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.